Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
DIS$112.23-0.91(-0.80%)Disney: Mickey Mouse To Lay Off Thousands9:36:11 AM ETNVDA$208.96+6.76(+3.34%)Is NVIDIA's Cheap Valuation an Opportunity to Invest in the Stock?9:36:07 AM ETTMUS$156.66-3.49(-2.18%)T-Mobile Brings More to the Holiday Mix: Deals on the Season’s Must-Have Tech, All-New T-Mix Plans and More9:36:02 AM ETDIS$112.23-0.91(-0.80%)Disney eyes thousands of layoffs, asks managers to target 20% savings: report9:34:05 AM ETPLTR$171.64-6.72(-3.77%)Palantir: The Stock Price Is Outrunning The Business9:34:00 AM ETPLTR$171.64-6.72(-3.77%)If You Invest $10,000 in Palantir Today, Here's What It Could Be Worth by 20309:33:37 AM ETCRM$216.02-10.08(-4.46%)Salesforce Climbs 22% in Six Months: Is the Stock Still Worth Buying?9:31:07 AM ETSAN$11.47+0.01(+0.09%)World faces €30 trillion financing gap, Santander report warns9:31:03 AM ETNET$274.13+9.03(+3.41%)JPMorgan upgrades Cloudflare (NET) to Overweight after selloff9:26:24 AM ETINTC$62.06+2.11(+3.52%)Intel Drops 31% in a Day as Data Center Sales Jump 78%9:14:00 AM ETPFE$30.74+0.04(+0.13%)Pfizer's Eliquis Price Gains Cover COVID Drop: Rapid Earnings Reaction9:13:02 AM ETPLTR$171.64-6.72(-3.77%)Burry vs Karp: One Year Later, Who Actually Won the Palantir Fight?9:06:03 AM ETGOOGL$279.20+0.17(+0.06%)Anthropic's Spending Commitments Are Soaring Towards $1 Trillion9:04:14 AM ETHD$332.69-8.49(-2.49%)Home Depot Stock Could Be Poised for a Turnaround. Here's How High It Could Go9:03:58 AM ETPNGAF$0.24+0.04(+17.53%)Peptide Therapies Are Changing the Future of Medicine — And the Market Could Reach $335 Billion9:01:24 AM ETLSE:TTE$83.36-1.64(-1.93%)TotalEnergies Marketing USA Signs Supply Agreement with SSF Imported Auto Parts for ELF Passenger Car Motor Oils9:01:19 AM ETPFE$30.74+0.04(+0.13%)Pfizer (PFE) Surpasses Q3 Earnings and Revenue Estimates9:00:49 AM ETSHOP$141.85-14.35(-9.19%)Shopify Operating Income Jumps 66%: Rapid Earnings Reaction9:00:30 AM ETMU$869.70+36.41(+4.37%)Micron or Nvidia: If I Could Only Buy and Hold One of These Artificial Intelligence (AI) Chip Stocks for the Next 5 Years, It Would Be This One9:00:00 AM ETGEV$910.18+47.73(+5.53%)GE Vernova Is Paying $9 Billion for Trench Group. Here's Why the Grid Is Crucial to the Electricity Supercycle.9:00:00 AM ETSPCX$139.73+3.39(+2.49%)SpaceX stock price 2027 forecast8:59:16 AM ETINTC$62.06+2.11(+3.52%)Intel Q3: What May Happen If 50% Of Total Revenue Declines In Coming Quarters (Upgrade)8:57:44 AM ETPLTR$171.64-6.72(-3.77%)Dan Ives Says Palantir Is Answering AI's Biggest Question: Where's the Money?8:55:03 AM ETGOOG$278.26+0.26(+0.09%)AI Stocks Lose $5 Trillion in 3 Weeks as Hedge Funds Go Underweight AI for the First Time Since 20238:54:17 AM ET

ICU · NASDAQ

SeaStar Medical Holding Corporation

$2.10 -0.10 (-4.55%)

Company overview

SeaStar Medical Holding Corporation is a medical device company that focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company develops and commercializes extracorporeal therapies that target the effector cells driving systemic inflammation, which causes direct tissue damage and secretes a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in several therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end-stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$6M
Employees
19
Headquarters
Denver, CO
Website
seastarmedical.com
CEO
Eric Schlorff
Listed
March 18, 2021
P/E
-0.51
Dividend yield
0.00%

Company financials

Revenue
$1.4M
Gross profit
$1.3M
Operating income
-$12M
EBITDA
-$12M
Net income
-$11.9M
EPS
-$4.10
Total assets
$11.3M
Total debt
$331,000
Gross margin
93.11%
Net margin
-828.62%
Earnings yield
-195.24%

Price chart

1.992.873.754.635.51
ICU 1D NASDAQ O2.26H2.38L2.12C2.20-0.04 (-1.85%)Vol45.52K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
ICUSeaStar Medical Holding Corporation Press release FDA Confirms SeaStar Medical Has Fulfilled the Post-Approval Study Requirements for QUELIMMUNE® for the Treatment of Sepsis-Associated Acute Kidney Injury (AKI) in Pediatric Patients GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Sepsis-Associated AKI GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release ICU Medical Announces Time of Third Quarter 2026 Earnings Conference Call GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026 GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release New ICD-10-PCS Codes are Now Available for the Use of GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026 GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release SeaStar Medical Congratulates H. David Humes, M.D. GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release Quoin Pharmaceuticals Releases New NETHERTON NOW Video: GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release ICU Medical to Participate in Upcoming Investor Conferences GlobeNewswire
ICUSeaStar Medical Holding Corporation Stock news SeaStar Medical Holding Corporation (ICU) Q2 2026 Earnings Call Transcript Seeking Alpha
ICUSeaStar Medical Holding Corporation Press release SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates GlobeNewswire
ICUSeaStar Medical Holding Corporation Stock news ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings Benzinga
ICUSeaStar Medical Holding Corporation Stock news ICU Medical Q2 Earnings Call Highlights MarketBeat
ICUSeaStar Medical Holding Corporation Press release ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026 GlobeNewswire
ICUSeaStar Medical Holding Corporation Press release ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call GlobeNewswire
See more
FAQ

Questions about SeaStar Medical Holding Corporation

What does SeaStar Medical Holding Corporation do?
SeaStar Medical Holding Corporation is a medical device company that focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company develops and commercializes extracorporeal therapies that target the effector cells driving systemic inflammation, which causes direct tissue damage and secretes a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in several therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end-stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
What is ICU's market cap?
SeaStar Medical Holding Corporation (ICU) is a listed stock with a live quote. The latest market cap on this page is $6M.
Where is SeaStar Medical Holding Corporation headquartered?
SeaStar Medical Holding Corporation is headquartered in Denver, CO.
How do I get ICU news from the API?
Call GET /v1/news?tickers=ICU. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does ICU news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for ICU, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the ICU price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs